Moderna’s experimental COVID-19 vaccine was granted fast track status by the Food and Drug Administration. Under the fast track pathway, the FDA aims to make approval decisions within six months. (Reuters)

LabCorp has expanded the availability of at-home coronavirus tests. The tests were limited to healthcare workers during the launch last month, but LabCorp is now making the test available to all individuals with symptoms and possible exposure to the virus. (Reuters)

Health official Dr. Anthony Fauci has testified before Congress, saying the U.S. could see more “suffering and death” if states reopen too soon. He warned that reopening too soon could lead to multiple outbreaks of COVID-19 all over the country. (CNBC)

Pfizer plans to expand coronavirus vaccine trials to thousands of participants in the fall, said CEO Albert Bourla. Pfizer will have data on which vaccine variation currently being tested works best in June or July. The later trials, expected to begin in September, will include thousands of people. (CNBC)

The U.S. could conduct 50 million tests every month by the fall, said Department of Health and Human Services official Brett Giroir. More than half of those tests will be done at the point of care and analyzed in hospitals and doctors’ offices. (Politico)